Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.

Journal: PloS one
Published Date:

Abstract

The peptides derived from envelope proteins have been shown to inhibit the protein-protein interactions in the virus membrane fusion process and thus have a great potential to be developed into effective antiviral therapies. There are three types of envelope proteins each exhibiting distinct structure folds. Although the exact fusion mechanism remains elusive, it was suggested that the three classes of viral fusion proteins share a similar mechanism of membrane fusion. The common mechanism of action makes it possible to correlate the properties of self-derived peptide inhibitors with their activities. Here we developed a support vector machine model using sequence-based statistical scores of self-derived peptide inhibitors as input features to correlate with their activities. The model displayed 92% prediction accuracy with the Matthew's correlation coefficient of 0.84, obviously superior to those using physicochemical properties and amino acid decomposition as input. The predictive support vector machine model for self- derived peptides of envelope proteins would be useful in development of antiviral peptide inhibitors targeting the virus fusion process.

Authors

  • Yongtao Xu
    School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Stranmillis Road, Belfast, Northern Ireland, United Kingdom.
  • Shui Yu
    School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Stranmillis Road, Belfast, Northern Ireland, United Kingdom.
  • Jian-Wei Zou
    School of Biotechnology and Chemical Engineering, Ningbo Institute of Technology, Zhejiang University, Ningbo, China.
  • Guixiang Hu
    School of Biotechnology and Chemical Engineering, Ningbo Institute of Technology, Zhejiang University, Ningbo, China.
  • Noorsaadah A B D Rahman
    Department of Chemistry, Faculty of Sciences, University of Malaya, Kuala Lumpur, Malaysia.
  • Rozana Binti Othman
    Drug Design & Development Research Group, University of Malaya, Kuala Lumpur, Malaysia.
  • Xia Tao
    State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, China.
  • Meilan Huang
    School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Stranmillis Road, Belfast, Northern Ireland, United Kingdom.